Brief: Dicot Q3 Pretax Loss Widens To SEK 3.2 Million
Nov 28 (Reuters) - Dicot AB DICOT.TE :
* JULY-SEPT NET SALES SEK 75,000
* Q3 PRETAX LOSS SEK 3.2 MILLION VERSUS LOSS SEK 1.4 MILLION
YEAR
AGO
* DURING Q3, WE CONTINUED OUR DEVELOPMENT EFFORTS RELATED TO
DRUG
CANDIDATE LIBIGUIN® BEFORE UPCOMING PHASE I STUDY TOGETHER WITH
OUR PARTNERS
Source text for Eikon: ID:nWkr3N04ff
Further company coverage: DICOT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Q2 Net Sales Sek 0.0 Million
Brief: Dicot Pharma Submits CTA In EU For Phase 2b Study Of LIB-01
Brief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue